|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/513 | |
| A61K 31/517 | |||
| A61K 9/20 | |||
| A61P 31/18 |
| (11) | Number of the document | 2586444 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12198385.2 |
| Date of filing the European patent application | 2005-12-02 | |
| (97) | Date of publication of the European application | 2013-05-01 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-25 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 632944 P | 2004-12-03 | US |
| (72) |
Pourkavoos, Nazaneen, US
Ney, James, R., US
Cruanes, Maria, T., US
Wu, Yunhui, US
Palkar, Saurabh, A., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
| (54) | Pharmaceutical formulation of carboxamide HIV integrase inhibitors containing a release rate control composition |
| Pharmaceutical formulation of carboxamide HIV integrase inhibitors containing a release rate control composition |